Inaktiver Wert

Andere Sprachen Champions Oncology Inc OTC Bulletin Board

Aktien

US15870P1093

Schlusskurs OTC Bulletin Board Andere Börsenplätze
- ^USD	-

13.03.	CHAMPIONS ONCOLOGY, INC. : Craig-Hallum senkt seine Meinung und wechselt zu Neutral	ZM
12.03.	Champions Oncology, Inc. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 31. Januar 2024	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023.	15.03.
Champions Oncology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	12.03.
Champions Oncology's US Laboratory has Acquired Distinguished CAP Accreditation	08.03.
Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023.	13.12.
Champions Oncology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023	12.12.
MORNING BID AMERICAS-Disinflation station	12.12.
North American Morning Briefing : Traders Eye -2-	12.12.
Champions Oncology, Inc.	02.11.
Champions Oncology Announces the Addition of Brady Davis as President	18.10.23
Champions Oncology, Inc. Appoints Brady Davis as President	17.10.23
Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023.	13.09.23
Champions Oncology : Reports Quarterly Revenue of $12.6 Million - Form 8-K	13.09.23
Champions Oncology, Inc. Reports Earnings Results for the First Quarter Ended July 31, 2023	13.09.23
Champions Oncology Announces a Multi-Year Agreement and Strategic Collaboration with BioVolume to Transform Reproducibility in Preclinical Oncology Efficacy Studies	02.08.23
Champions Oncology Enters Multiyear Deal With BioVolume to Better Evaluate Cancer Studies	01.08.23
Champions Oncology, Inc. Announces Multi-Year Agreement and Strategic Collaboration with BioVolume to Transform Reproducibility in Preclinical Oncology Efficacy Studies	01.08.23
Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023.	24.07.23
Champions Oncology, Inc. Reports Earnings Results for the Full Year Ended April 30, 2023	24.07.23
Champions Oncology, Inc. Reports Earnings Results for the Fourth Quarter Ended April 30, 2023	24.07.23
Champions Oncology Forms Therapeutic Discovery Platform Unit Corellia AI	17.04.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Champions Oncology Inc OTC Bulletin Board

Aktien

US15870P1093

Andere Sprachen

Filter